Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation-Positive Non-Small Cell Lung Cancer
Isomoto, Kohsuke, Haratani, Koji, Hayashi, Hidetoshi, Shimizu, Shigeki, Tomida, Shuta, Niwa, Takashi, Yokoyama, Toshihide, Fukuda, Yasushi, Chiba, Yasutaka, Kato, Ryoji, Tanizaki, Junko, Tanaka, Kaoru, Takeda, Masayuki, Ogura, Takashi, Ishida, Tadashi, Ito, Akihiko, Nakagawa, Kazuhiko
Published in Clinical cancer research (15.04.2020)
Published in Clinical cancer research (15.04.2020)
Get full text
Journal Article
Impact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer
Yamagata, Akira, Yokoyama, Toshihide, Fukuda, Yasushi, Ishida, Tadashi
Published in Cancer chemotherapy and pharmacology (01.02.2021)
Published in Cancer chemotherapy and pharmacology (01.02.2021)
Get full text
Journal Article
Fatal Immune Checkpoint Inhibitor-related Pancreatitis
Ueno, Masayuki, Tsuji, Yoshihisa, Yokoyama, Toshihide, Koyama, Takashi, Uenishi, Yosuke, Ishida, Etsuji, Mizuno, Motowo
Published in Internal Medicine (15.12.2021)
Published in Internal Medicine (15.12.2021)
Get full text
Journal Article
TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells
Nozawa, Katsura, Kawabata-Shoda, Eri, Doihara, Hitoshi, Kojima, Ryosuke, Okada, Hidetsugu, Mochizuki, Shinobu, Sano, Yorikata, Inamura, Kohei, Matsushime, Hitoshi, Koizumi, Tomonobu, Yokoyama, Toshihide, Ito, Hiroyuki
Published in Proceedings of the National Academy of Sciences - PNAS (03.03.2009)
Published in Proceedings of the National Academy of Sciences - PNAS (03.03.2009)
Get full text
Journal Article
Tepotinib‐induced hand‐foot skin reaction
Yamano, Takafumi, Yokoyama, Toshihide, Ishida, Tadashi
Published in Respirology case reports (01.05.2024)
Published in Respirology case reports (01.05.2024)
Get full text
Journal Article
Alectinib re-challenge in small cell lung cancer transformation after chemotherapy failure in a patient with ALK-positive lung cancer: A case report
Yamagata, Akira, Yokoyama, Toshihide, Fukuda, Yasushi, Ishida, Tadashi
Published in Respiratory medicine case reports (01.01.2021)
Published in Respiratory medicine case reports (01.01.2021)
Get full text
Journal Article
Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan
Edahiro, Ryuya, Kanazu, Masaki, Kurebe, Hiroyuki, Mori, Masahide, Fujimoto, Daichi, Taniguchi, Yoshihiko, Suzuki, Hidekazu, Hirano, Katsuya, Yokoyama, Toshihide, Morita, Mitsunori, Fukuda, Yasushi, Uchida, Junji, Makio, Takeshi, Tamiya, Motohiro
Published in PloS one (31.07.2019)
Published in PloS one (31.07.2019)
Get full text
Journal Article
Effects of novel TRPA1 receptor agonist ASP7663 in models of drug-induced constipation and visceral pain
Kojima, Ryosuke, Nozawa, Katsura, Doihara, Hitoshi, Keto, Yoshihiro, Kaku, Hidetaka, Yokoyama, Toshihide, Itou, Hiroyuki
Published in European journal of pharmacology (15.01.2014)
Published in European journal of pharmacology (15.01.2014)
Get full text
Journal Article
Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status
Ikeda, Satoshi, Yoshioka, Hiroshige, Ikeo, Satoshi, Morita, Mitsunori, Sone, Naoyuki, Niwa, Takashi, Nishiyama, Akihiro, Yokoyama, Toshihide, Sekine, Akimasa, Ogura, Takashi, Ishida, Tadashi
Published in BMC cancer (28.11.2017)
Published in BMC cancer (28.11.2017)
Get full text
Journal Article
Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non–small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study
Kawachi, Hayato, Tamiya, Motohiro, Tamiya, Akihiro, Ishii, Seigo, Hirano, Katsuya, Matsumoto, Hirotaka, Fukuda, Yasushi, Yokoyama, Toshihide, Kominami, Ryota, Fujimoto, Daichi, Hosoya, Kazutaka, Suzuki, Hidekazu, Hirashima, Tomonori, Kanazu, Masaki, Sawa, Nobuhiko, Uchida, Junji, Morita, Mitsunori, Makio, Takeshi, Hara, Satoshi, Kumagai, Toru
Published in Investigational new drugs (01.02.2020)
Published in Investigational new drugs (01.02.2020)
Get full text
Journal Article
Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)
Wakuda, Kazushige, Kenmotsu, Hirotsugu, Sato, Yuki, Nakamura, Atsushi, Akamatsu, Hiroaki, Tachihara, Motoko, Miura, Satoru, Yokoyama, Toshihide, Mori, Keita, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki
Published in BMC cancer (25.09.2023)
Published in BMC cancer (25.09.2023)
Get full text
Journal Article
Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study
Hosoya, Kazutaka, Fujimoto, Daichi, Morimoto, Takeshi, Kumagai, Toru, Tamiya, Akihiro, Taniguchi, Yoshihiko, Yokoyama, Toshihide, Ishida, Tadashi, Matsumoto, Hirotaka, Hirano, Katsuya, Kominami, Ryota, Tomii, Keisuke, Suzuki, Hidekazu, Hirashima, Tomonori, Tanaka, Satoshi, Uchida, Junji, Morita, Mitsunori, Kanazu, Masaki, Mori, Masahide, Nagata, Kenji, Fukuda, Ikue, Tamiya, Motohiro
Published in BMC cancer (01.04.2021)
Published in BMC cancer (01.04.2021)
Get full text
Journal Article
A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401
Ninomiya, Kiichiro, Yokoyama, Toshihide, Hotta, Katsuyuki, Oze, Isao, Katsui, Kuniaki, Hata, Tae, Yoshioka, Hiroshige, Bessho, Akihiro, Hosokawa, Shinobu, Kuyama, Shoichi, Kudo, Kenichiro, Kozuki, Toshiyuki, Harada, Daijiro, Yasugi, Masayuki, Murakami, Toshi, Nakanishi, Masamoto, Takigawa, Nagio, Maeda, Yoshinobu, Kiura, Katsuyuki
Published in Supportive care in cancer (01.09.2021)
Published in Supportive care in cancer (01.09.2021)
Get full text
Journal Article
Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS)
Katakami, Nobuyuki, Yokoyama, Toshihide, Morita, Satoshi, Okamoto, Tatsuro, Urata, Yoshiko, Hattori, Yoshihiro, Iwamoto, Yasuo, Sato, Yuki, Ikeda, Norihiko, Takahashi, Toshiaki, Daga, Haruko, Oguri, Tetsuya, Fujisaka, Yasuhito, Nishino, Kazumi, Sugawara, Shunichi, Kozuki, Toshiyuki, Oki, Masahide, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Published in International journal of clinical oncology (01.01.2023)
Published in International journal of clinical oncology (01.01.2023)
Get full text
Journal Article
Histologic transformation of epidermal growth factor receptor–mutated lung cancer
Fujimoto, Daichi, Akamatsu, Hiroaki, Morimoto, Takeshi, Wakuda, Kazushige, Sato, Yuki, Kawa, Yoshitaka, Yokoyama, Toshihide, Tamiya, Motohiro, Hiraoka, Ryota, Shingu, Naoki, Ikeda, Hideki, Tamiya, Akihiro, Kanazu, Masaki, Miyauchi, Eisaku, Miura, Satoru, Yanai, Masaaki, Yomota, Makiko, Morinaga, Ryotaro, Yokoi, Takashi, Hata, Akito, Suzuki, Hidekazu, Matsumoto, Hirotaka, Sakata, Shinya, Furuya, Naoki, Harutani, Yuhei, Nakachi, Ichiro, Otsuki, Ayumu, Uematsu, Shinya, Hara, Satoshi, Yokoo, Keiki, Sugimoto, Takeya, Yamamoto, Nobuyuki
Published in European journal of cancer (1990) (01.05.2022)
Published in European journal of cancer (1990) (01.05.2022)
Get full text
Journal Article
Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab
Morita, Mitsunori, Tamiya, Motohiro, Fujimoto, Daichi, Tamiya, Akihiro, Suzuki, Hidekazu, Hirano, Katsuya, Fukuda, Yasushi, Yokoyama, Toshihide, Kominami, Ryota, Kanazu, Masaki, Uchida, Junji, Hara, Satoshi, Yamashita, Shuji, Tomioka, Hiromi
Published in BMC cancer (03.02.2020)
Published in BMC cancer (03.02.2020)
Get full text
Journal Article
Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M–positive non–small cell lung cancer: West Japan Oncology Group 8815L/LPS study
Takahama, Takayuki, Azuma, Koichi, Shimokawa, Mototsugu, Takeda, Masayuki, Ishii, Hidenobu, Kato, Terufumi, Saito, Haruhiro, Daga, Haruko, Tsuboguchi, Yuko, Okamoto, Isamu, Otsubo, Kohei, Akamatsu, Hiroaki, Teraoka, Shunsuke, Takahashi, Toshiaki, Ono, Akira, Ohira, Tatsuo, Yokoyama, Toshihide, Sakai, Kazuko, Yamamoto, Nobuyuki, Nishio, Kazuto, Nakagawa, Kazuhiko
Published in Cancer (01.01.2020)
Published in Cancer (01.01.2020)
Get full text
Journal Article
Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study)
Tsubata, Yukari, Hotta, Takamasa, Hamai, Kosuke, Furuya, Naoki, Yokoyama, Toshihide, Saito, Ryota, Nakamura, Atsushi, Masuda, Takeshi, Hamaguchi, Megumi, Kuyama, Shoichi, Honda, Ryoichi, Senoo, Tadashi, Nakanishi, Masamoto, Yamasaki, Masahiro, Ishikawa, Nobuhisa, Fujitaka, Kazunori, Kubota, Tetsuya, Ohtsu, Hiroshi, Kobayashi, Kunihiko, Isobe, Takeshi
Published in Therapeutic advances in medical oncology (2022)
Published in Therapeutic advances in medical oncology (2022)
Get full text
Journal Article
Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L)
Sakai, Kazuko, Takahama, Takayuki, Shimokawa, Mototsugu, Azuma, Koichi, Takeda, Masayuki, Kato, Terufumi, Daga, Haruko, Okamoto, Isamu, Akamatsu, Hiroaki, Teraoka, Shunsuke, Ono, Akira, Ohira, Tatsuo, Yokoyama, Toshihide, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko, Nishio, Kazuto
Published in Molecular oncology (01.01.2021)
Published in Molecular oncology (01.01.2021)
Get full text
Journal Article